LENZ Therapeutics Inc.

LENZ | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.08

+$0.01 (+0.25%)

At close: Sep 21, 2026, 4:00 PM ET

$4.08

$0 (0.00%)

Pre-market: Sep 22, 2026, 5:02 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-82.13M	-49.77M	-69.97M	-101.05M	-70.76M	-68.37M
Depreciation & Amortization	-3.12M	58K	15K	8.35M	734K	121K
Stock-Based Compensation	12.55M	6.37M	1.34M	n/a	n/a	n/a
Other Working Capital	7.95M	-8.81M	8.55M	-7.4M	-4.32M	1.12M
Other Non-Cash Items	279K	-2.95M	-1.18M	11.93M	19.67M	57.82M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	3.25M	-13.09M	9.41M	-7.21M	-2.5M	1.71M
Operating Cash Flow	-69.17M	-59.39M	-60.38M	-87.98M	-52.85M	-8.72M
Capital Expenditures	-827K	-468K	-30K	-6.59M	-5.74M	-1.55M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-280.8M	-241.91M	-52.09M	-405.52M	n/a	n/a
Sales Maturities Of Investments	205.96M	87.9M	22.5M	170.25M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-75.67M	-154.48M	-29.62M	-241.86M	-5.74M	-1.55M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	-79K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	119.49M	-2.48M	n/a	306K	n/a
Financial Cash Flow	149.75M	199M	80.7M	597K	417.47M	30.08M
Net Cash Flow	4.91M	-14.87M	-9.3M	-329.25M	357.16M	19.81M
Free Cash Flow	-70M	-59.86M	-60.41M	-94.57M	-58.59M	-10.27M
Adj. Free Cash Flow	-82.54M	-66.22M	-61.75M	-94.57M	-58.59M	-10.27M
Maintenance CapEx	n/a	-468K	-30K	-4.84M	-734K	-121K
Growth CapEx	-827K	n/a	n/a	-1.75M	-5.01M	-1.42M
Owner Earnings	-69.17M	-59.86M	-60.41M	-92.82M	-53.59M	-8.84M